A B-cell depleting agent for the treatment of atherosclerosis

• 1. 用于治疗动脉粥样硬化的B细胞耗竭剂 [P] . 中国专利： CN102271710A . 2011-12-07
• 2. 包含耗竭性抗CD4单克隆抗体的抗癌T细胞治疗剂辅助用组合物及其用途 [P] . 中国专利： CN111989118A . 2020-11-24
• 3. B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME [P] . HUE034127T2 . 2018-01-29

  机译： B细胞耗竭剂，如抗CD20抗体或其片段，用于治疗慢性疲劳综合征

• 4. B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME [P] . HRP20170687T1 . 2017-09-08

  机译： B细胞耗竭剂，如抗CD20抗体或其片段，用于治疗慢性疲劳综合征

• 5. B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME [P] . LT2235060T . 2017-07-25

  机译： B细胞耗竭剂，如抗CD20抗体或其片段，用于治疗慢性疲劳综合征

• 1. Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options [J] . Shuna Yao, Jie Ma, Yan Zhao, 中国癌症研究（英文版） . 2017,第001期
• 2. B-cell depleting agents for ANCA vasculitides: A new therapeutic approach [J] . Gómez-PuertaJ.A., QuintanaL.F., StoneJ.H., Autoimmunity reviews . 2012,第9期
• 3. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment [J] . G. Cambridge, H.C Perry, L Nogueira, Journal of Autoimmunity . 2014,第Null期
• 4. Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion? [J] . Dolff S, Abdulahad WH, Bijl M Lupus . 2009,第7期
• 5. Agent Based Modeling of Atherosclerosis: A Concrete Help in Personalized Treatments [C] . Francesco Pappalardo, Alessandro Cincotti, Alfredo Motta, International conference on intelligent computing;CICI 2009 . 2009
• 6. Design and Synthesis of Gold Nanoparticle Contrast Agents for Atherosclerosis Imaging with Computed tomography. [D] . Chhour, Peter. 2017
• 7. Glutathione Depletion Induced by c-Myc Downregulation Triggers Apoptosis on Treatment with Alkylating Agents [O] . Annamaria Biroccio, Barbara Benassi, Francesco Fiorentino, 2004
• 8. Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy [O] . S Faderl, A Ferrajoli, O Frankfurt, 2008

• 1. The number of antihypertensive agents simply reflects the grade and the risk of atherosclerosis in patients with type 2 diabetes mellitus [J] . Hiroyuki Ito ,Mariko Abe ,Masahiro Shinozaki . 糖尿病（英文） . 2013,第4期
• 2. Diagnosis and treatment of pediatric anaplastic lymphoma kinasepositive large B-cell lymphoma:A case report [J] . Meng Zhang ,Ling Jin ,Yan-Long Duan . 世界临床病例杂志 . 2021,第017期
• 3. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma [J] . Michele Merli ,Giuseppe Carli ,Luca Arcaini . 世界胃肠病学杂志：英文版 . 2016,第38期
• 4. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment [J] . Carlo Visco ,Silvia Finotto . 世界胃肠病学杂志：英文版 . 2014,第32期
• 5. 重组人粒细胞巨噬细胞集落刺激因子凝胶剂用于深Ⅱ°烧伤创面治疗的临床疗效 [C] . 郭万里 ,段鹏 ,雷晋 . 中国康复医学会修复重建外科专业委员会第19次学术交流会暨中国医师协会烧伤科医师分会2012年年会 . 2012
• 6. 重塑肿瘤微环境杂合纳米笼耗竭肿瘤浸润B细胞用于增强肿瘤治疗效果的研究 [A] . 管丽 . 2021